Results 121 to 130 of about 2,369,861 (245)

PAMD-Ch17, a Polymeric Analog of Plerixafor, Induces Mitochondrial Dysfunction in T-ALL Cells Independent of CXCR4. [PDF]

Mol Cancer Ther
Lam C, Dhir A, Mitro A, Jogdeo CM, Panda S, Kapoor E, Tang S, Rivero VJ, McIntyre EM, Coulter DW, Xiao P, Black AR, Hewitt K, Romanova S, Swenson SA, Oupicky D, Hyde RK.   +16 more
europepmc   +1 more source

Neurologic Manifestations of Long COVID Affect Adult Females More Severely Than Males

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To characterize differences in neurologic manifestations of postacute sequelae of SARS‐CoV‐2 infection (Neuro‐PASC) between females and males. Methods Cross‐sectional study of the first consecutive 261 posthospitalization Neuro‐PASC (PNP) and 2068 nonhospitalized Neuro‐PASC (NNP) patients evaluated at the Neuro‐COVID clinic between ...
Hannah Kopinsky, Melissa Lopez, Janet Miller, Millenia Jimenez, Eric M. Liotta, Igor J. Koralnik   +5 more
wiley   +1 more source

Intergenerational socioeconomic mobility and adulthood all-cause mortality in the Hispanic community health study/study of Latinos. [PDF]

Am J Epidemiol
Whalen AM, Ma W, Filigrana Villegas PA, Perreira KM, Cai J, Cordero C, Daviglus ML, Kaplan RC, Lee DJ, Llabre MM, Penedo FJ, Pichardo MS, Pirzada A, Suglia SF, Gallo LC, Isasi CR.   +15 more
europepmc   +1 more source

Intracerebral Hemorrhage Induces Monocyte TNF Signaling in Patients That Is Suppressed by BAF312

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Intracerebral hemorrhage (ICH) causes high morbidity and mortality, with neurotoxic inflammation driven by infiltrating monocytes. This study is an in‐depth longitudinal examination of the immune response during the first week of ICH in the presence and absence of the immunomodulatory drug BAF312 (Siponimod).
Jonathan Howard DeLong, Sebastian Díaz‐Pérez, Kevin Navin Sheth, Jang‐Ho Cha, C. J. Malanga, Patricia G. M. Wagner, Nicole Pezous, Aurelie Hanin, Kyle B. Walsh, H. E. Hinson, Lauren Hachmann Sansing   +10 more
wiley   +1 more source

P765: Leveraging dbSNP for screening rare and novel genetic variants in disease and cancer research

Genetics in Medicine Open
Lon Phan, Hua Zhang, Qiang Wang, Eugene Shekhtma, Aravinthan Ramanathan, Ricardo Villamarin-Salomon, Tim Hefferon, Brandi Kattman   +7 more
doaj   +1 more source

The tau biomarker cascade is condensed in Down syndrome compared with sporadic Alzheimer's disease. [PDF]

Brain
Zammit MD, Bruzzone H, Cody KA, Morse J, Wilson R, Bettcher BT, McLachlan MJ, McVea AK, DiFilippo AH, Carey FJ, Janelidze S, Hansson O, Price JC, Laymon CM, Minhas DS, Luo W, Rosas HD, Lai F, Lee JH, Lao PJ, Ances BM, Krinsky-McHale SJ, Hom CL, Hartley SL, Zaman SH, Johnson SC, Cohen AD, Head E, Mapstone ME, Handen BL, Christian BT, Tudorascu DL, Langhough RE, Betthauser TJ, Alzheimer Biomarker Consortium–Down Syndrome .   +34 more
europepmc   +1 more source

Progressive Parkinsonism in PPP2R5D‐Related Neurodevelopmental Disorder

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT PPP2R5D‐related neurodevelopmental disorder (Houge–Janssens syndrome type 1) is a rare autosomal dominant condition characterized by macrocephaly, intellectual disability, and epilepsy. Progressive parkinsonism is an emerging adult phenotype that neurologists should be aware of since timely genetic diagnosis opens the door to disease‐modifying
Katerina Bernardi, Enrique Gonzalez Saez‐Diez, Joshua Rong, Beril Ay, Shabbir Merchant, Kathryn Yang, Darius Ebrahimi‐Fakhari   +6 more
wiley   +1 more source

NIH Grant Watch

BioTechniques, 2007
doaj   +5 more sources

HERV-K/HML-2 Suppression Using Antiretroviral Therapy in Amyotrophic Lateral Sclerosis (ALS)

Neurotherapeutics
Darshan Pandya, M.D., Marta Garcia-Montojo, Ph.D., Justin Kwan, Ph.D., Gina Norato, Melina Jones, Ph.D., Ajay Verma, Erez Eltan, Sara Rau, Avindra Nath, M.D.   +8 more
doaj   +1 more source

Temporal Evaluation of the Metabolic Vulnerability Index and Its Components in a Heart Failure Clinical Trial Population. [PDF]

J Appl Lab Med
Rafi R, Downie CG, Kuku KO, Remaley AT, Shearer JJ, Roger VL.   +5 more
europepmc   +1 more source